Education
About Us
Working with TipRanks
Follow Us
Lincoln Pharmaceuticals Ltd (IN:LINCOLN)
:LINCOLN
LINCOLN Stock Chart & Stats
₹496.60
-₹14.55(-1.74%)
At close: 4:00 PM EST
₹496.60
-₹14.55(-1.74%)
Day’s Range― - ―
52-Week Range₹439.95 - ₹679.45
Previous CloseN/A
Volume57.32K
Average Volume (3M)1.66K
Market Cap
₹12.97B
Enterprise Value₹12.88B
Total Cash (Recent Filing)₹1.96B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)14.8
Beta1.51
Next Earnings
May 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.37%
Share Statistics
EPS (TTM)14.28
Shares Outstanding20,029,728
10 Day Avg. Volume3,133
30 Day Avg. Volume1,664
Financial Highlights & Ratios
PEG Ratio-1.14
Price to Book (P/B)1.65
Price to Sales (P/S)1.77
P/FCF Ratio14.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthAn almost debt-free balance sheet and near-zero debt-to-equity provide durable financial flexibility: supports capex, R&D, and geographic expansion without refinancing risk, lowers solvency risk in downturns, and preserves strategic optionality for M&A or investments over the next 2–6 months.
Improving Free Cash FlowA sharp rebound in free cash flow that now covers a large portion of net income signals improving cash conversion and liquidity. This strengthens the company’s ability to self-fund growth, pay suppliers, and maintain investment without relying on external financing over the medium term.
Stable Revenue & Healthy MarginsConsistent top-line expansion and gross margins north of 50% indicate durable product economics and manufacturing/portfolio strength. Even with recent margin pressure, high gross margins provide a buffer to absorb cost volatility and sustain operating profitability over several quarters.
Bears Say
Margin CompressionMaterial margin contraction year-over-year points to structural cost pressure or mix shifts that can erode earnings power if persistent. Lower EBITDA and net margins reduce reinvestment capacity and ROE, making profitability more sensitive to revenue stalls or input-cost inflation over coming quarters.
Cash Conversion VariabilityOperating cash below accounting profit and volatile coverage ratios reflect working-capital sensitivity and inconsistent cash realization. Persistent variability can stress liquidity planning, reduce free-cash reliability for investments, and complicate forecasting across multiple reporting periods.
Earnings/ROE SofteningROE decline and slightly negative EPS growth suggest returns are being diluted by equity growth or weaker margin conversion. If profitability does not re-accelerate, capital efficiency could remain muted, limiting long-term shareholder return and signaling pressure on operating leverage.
Lincoln Pharmaceuticals Ltd News
LINCOLN FAQ
What was Lincoln Pharmaceuticals Ltd’s price range in the past 12 months?
Lincoln Pharmaceuticals Ltd lowest stock price was ₹439.95 and its highest was ₹679.45 in the past 12 months.
What is Lincoln Pharmaceuticals Ltd’s market cap?
Lincoln Pharmaceuticals Ltd’s market cap is ₹12.97B.
When is Lincoln Pharmaceuticals Ltd’s upcoming earnings report date?
Lincoln Pharmaceuticals Ltd’s upcoming earnings report date is May 21, 2026 which is in 93 days.
How were Lincoln Pharmaceuticals Ltd’s earnings last quarter?
Lincoln Pharmaceuticals Ltd released its earnings results on Feb 12, 2026. The company reported ₹14.279 earnings per share for the quarter, beating the consensus estimate of N/A by ₹14.279.
Is Lincoln Pharmaceuticals Ltd overvalued?
According to Wall Street analysts Lincoln Pharmaceuticals Ltd’s price is currently Overvalued.
Does Lincoln Pharmaceuticals Ltd pay dividends?
Lincoln Pharmaceuticals Ltd pays a Annually dividend of ₹1.8 which represents an annual dividend yield of 0.37%. See more information on Lincoln Pharmaceuticals Ltd dividends here
What is Lincoln Pharmaceuticals Ltd’s EPS estimate?
Lincoln Pharmaceuticals Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lincoln Pharmaceuticals Ltd have?
Lincoln Pharmaceuticals Ltd has 20,029,728 shares outstanding.
What happened to Lincoln Pharmaceuticals Ltd’s price movement after its last earnings report?
Lincoln Pharmaceuticals Ltd reported an EPS of ₹14.279 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 15.516%.
Which hedge fund is a major shareholder of Lincoln Pharmaceuticals Ltd?
Currently, no hedge funds are holding shares in IN:LINCOLN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.
Technical Analysis
Kilitch Drugs (India) Limited
―
Kopran Limited
―
Themis Medicare Limited
―
Wanbury Limited
―
Anuh Pharma Limited
―